Evalve Inc. [a wholly owned subsidiary of Abbott Vascular Inc.] Revenue and Competitors
Estimated Revenue & Valuation
- Evalve Inc. [a wholly owned subsidiary of Abbott Vascular Inc.]'s estimated annual revenue is currently $17.6M per year.
- Evalve Inc. [a wholly owned subsidiary of Abbott Vascular Inc.]'s estimated revenue per employee is $251,000
Employee Data
- Evalve Inc. [a wholly owned subsidiary of Abbott Vascular Inc.] has 70 Employees.
- Evalve Inc. [a wholly owned subsidiary of Abbott Vascular Inc.] grew their employee count by 0% last year.
Evalve Inc. [a wholly owned subsidiary of Abbott Vascular Inc.]'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | Controller | Reveal Email/Phone |
2 | Director QA | Reveal Email/Phone |
3 | Sr Accountant | Reveal Email/Phone |
4 | Manufacturing Engineering | Reveal Email/Phone |
5 | Manufacturing Engineering Technician | Reveal Email/Phone |
6 | Sr. Product Performance Engineer | Reveal Email/Phone |
7 | QA Lab Head | Reveal Email/Phone |
8 | Assembler | Reveal Email/Phone |
Evalve Inc. [a wholly owned subsidiary of Abbott Vascular Inc.] Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Evalve Inc. [a wholly owned subsidiary of Abbott Vascular Inc.]?
Evalve was incorporated in 1999 to design, develop, manufacture and market innovative devices to enable percutaneous repair of cardiac valves. The company’s initial products are intended to reduce the risks, trauma and cost associated with current open, arrested heart surgical options. The company’s present development and clinical efforts are focused on mitral valve repair with the MitraClip® system. Evalve obtained CE mark approval in 2008 for the MitraClip® system, the world’s first percutaneous valve repair system. In October, 2009 Evalve, Inc. was acquired by Abbott Vascular, Inc. Visit us at www.abbottvascular.com for current information about the company.
keywords:N/A
N/A
Total Funding
70
Number of Employees
$17.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 70 | 17% | N/A |
#2 | $3.2M | 70 | 8% | N/A |
#3 | $9.5M | 70 | 13% | N/A |
#4 | $15.4M | 70 | 6% | N/A |
#5 | $5.4M | 70 | -55% | $471.1M |